Printer Friendly

Proton Pump Inhibitor Use Tied to Hip Fracture in Dialysis Patients; Correlation between PPI and hip fracture persisted for subgroups with low, medium, high PPI use.

FRIDAY, Sept. 28, 2018 (HealthDay News) -- Proton pump inhibitor (PPI) use is associated with increased risk of hip fracture among dialysis patients, according to a study published online Sept. 27 in the Clinical Journal of the American Society of Nephrology.

Chandan Vangala, M.D., from Baylor College of Medicine in Houston, and colleagues examined the impact of PPI use on hip fracture risk in a high-risk subset of patients with end-stage kidney disease requiring hemodialysis between 2009 and 2014. Eligible cases were matched with 10 controls on index date; data were included for 4,551 cases and 45,510 controls. PPI and histamine-2 receptor antagonist use were identified from Medicare Part D claims covering three years prior to the index date.

The researchers found that a larger proportion of cases than controls had prior PPI use (70 versus 63 percent) or histamine-2 receptor antagonist use (25 versus 23 percent). PPI use correlated with increased risk of hip fracture (adjusted odds ratio, 1.19). The correlation persisted in subgroups of low, moderate, and high PPI use, with adjusted odds ratios of 1.16, 1.21, and 1.19, respectively.

"Among patients with end-stage kidney disease on hemodialysis, PPIs, and not histamine-2 receptor antagonists, were associated with hip fracture events," the authors write.

Abstract/Full Text (subscription or payment may be required) Editorial (subscription or payment may be required)

COPYRIGHT 2018 HealthDay
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Physician's Briefings
Date:Sep 28, 2018
Previous Article:CDC: Congenital Syphilis More Than Doubled Since 2013; Congenital syphilis up from 362 cases in 2013 to 918 in 2017, with 46.17 percent increase...
Next Article:Cardioverter-Defibrillator Vests Do Not Cut Sudden Death Post MI; No drop in arrhythmic death among patients with acute MI, ejection fraction of less...

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |